Bristol-Myers Squibb Co.’s recent filing unveils that its Chief Executive Officer BOERNER CHRISTOPHER S. acquired Company’s shares for reported $99560.0 on Dec 05 ’23. In the deal valued at $49.78 per share,2,000 shares were bought. As a result of this transaction, BOERNER CHRISTOPHER S. now holds 82,672 shares worth roughly $4.24 million.
Then, BOERNER CHRISTOPHER S. bought 3,071 shares, generating $150,049 in total proceeds. Upon buying the shares at $48.86, the Chief Executive Officer now owns 79,384 shares.
Before that, Samuels Theodore R. II bought 8,500 shares. Bristol-Myers Squibb Co. shares valued at $423,385 were divested by the Director at a price of $49.81 per share. As a result of the transaction, Samuels Theodore R. II now holds 35,500 shares, worth roughly $1.82 million.
Societe Generale downgraded its Bristol-Myers Squibb Co. [BMY] rating to a Hold from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Redburn Atlantic’s analysts, who decreased its forecast for the stock in early February from “a Buy” to “a Neutral”. BofA Securities also remained covering BMY and has decreased its forecast on January 03, 2024 with a “Neutral” recommendation from previously “Buy” rating. Cantor Fitzgerald revised its rating on November 15, 2023. It rated BMY as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of BMY
On Friday, Bristol-Myers Squibb Co. [NYSE:BMY] saw its stock fall -0.16% to $51.32. Over the last five days, the stock has lost -5.37%. Bristol-Myers Squibb Co. shares have risen nearly 0.02% since the year began. Nevertheless, the stocks have fallen -25.53% over the past one year. While a 52-week high of $71.07 was reached on 03/13/24, a 52-week low of $47.58 was recorded on 02/06/24. SMA at 50 days reached $51.09, while 200 days put it at $55.26. A total of 9.09 million shares were traded, compared to the trading of 10.99 million shares in the previous session.
Levels Of Support And Resistance For BMY Stock
The 24-hour chart illustrates a support level at 50.91, which if violated will result in even more drops to 50.50. On the upside, there is a resistance level at 51.59. A further resistance level may holdings at 51.86. The Relative Strength Index (RSI) on the 14-day chart is 44.36, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.63, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 85.16%. Stochastics %K at 16.45% indicates the stock is a buying.
How much short interest is there in Bristol-Myers Squibb Co.?
A steep rise in short interest was recorded in Bristol-Myers Squibb Co. stocks on Mar 15, 2024, growing by 5.76 million shares to a total of 37.25 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 31.49 million shares. There was a rise of 15.46%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 1.84% of the overall stock float, the days-to-cover ratio (short ratio) rose to 1.89.
The most recent change occurred on November 09, 2023 when Deutsche Bank began covering the stock and recommended ‘”a Hold”‘ rating along with a $55 price target.
